Biocon Ltd, Asia’s premier Biopharmaceuticals company, today appointed Dr Christiane Hamacherh as CEO of Biocon Biologics India Ltd. Chief Executive Officer (CEO).
Dr Hamacher, who has more than 20 years of leadership experience, has been with Roche, Basel, Switzerland since 2007 and prior to that spent 10 years at Schering AG, Berlin, Germany, according to a press release here onn Saturday.
Commenting on the appointment Bicon, Chairperson and Managing Director Kiran Mazumdar-Shaw said that “Christiane joins us at a critical inflexion point in the business as we build our stature in the large and growing opportunity for biosimilar biologics. I am confident that she will successfully lead the company to become a major global player in the near future”.
Dr Hamacher, during her long career in the pharmaceutical industry, she has built expertise in the areas of oncology, virology, CNS, cardiovascular, gynaecology, diagnostics, dermatology, rheumatology and rare diseases. She holds a Ph.D. in Molecular Biology (Oncology)from the University Clinic Bergmannsheil / University of Bochum, Germany. She also studied Economics at the University of Hagen, Germany. (UNI)
Dr Christiane Hamacher was appointed as CEO of Biocon Biologics India Ltd, a wholly owned subsidiary of Biocon Ltd,
